![Chandra D. Lovejoy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chandra D. Lovejoy
Consejero General en
ERASCA, INC.
.
Perfil
Chandra D.
Lovejoy is currently the Chief Regulatory Affairs Officer at Erasca, Inc. Prior to this, Chandra held several positions in the pharmaceutical industry.
From 2005 to 2007, Chandra worked at Genentech, Inc. as a Manager-Regulatory Affairs.
In 2014, Chandra joined Sierra Oncology, Inc. as the Senior VP-Global Regulatory Affairs & Head-Quality, and worked there until 2017.
From 2007 to 2014, Chandra served as the Vice President-Global Regulatory Affairs at Endocyte, Inc. Chandra's most recent former position was as the Vice President-Regulatory Affairs at G1 Therapeutics, Inc. from 2017 to 2021.
Chandra's educational background includes a graduate degree from San Diego State University and an undergraduate degree from the University of San Francisco.
Cargos activos de Chandra D. Lovejoy
| Empresas | Cargo | Inicio |
|---|---|---|
| ERASCA, INC. | Consejero General | - |
Antiguos cargos conocidos de Chandra D. Lovejoy.
| Empresas | Cargo | Fin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Consejero General | 01/04/2021 |
| SIERRA ONCOLOGY, INC. | Consejero General | 01/01/2017 |
| ENDOCYTE, INC. | Consejero General | 01/01/2014 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Consejero General | 01/11/2007 |
Formación de Chandra D. Lovejoy.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
57
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
- Bolsa de valores
- Insiders
- Chandra D. Lovejoy
